Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Selexipag on coagulation and fibrinolysis in chronic thromboembolic pulmonary hypertension
jRCT1021240025Recruiting
- Sponsor
- Masaya Higashioka
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of selexipag in chronic thromboembolic pulmonary hypertension (CTEPH), sponsored by Masaya Higashioka. Primary endpoints: Plasma clot lysis time, Plasminogen level and 4 more. Started Sep 2024; status: recruiting.
02
Drugs
selexipag
03
Conditions
chronic thromboembolic pulmonary hypertension (CTEPH)
Beyond the preview
Go deeper on jRCT1021240025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1021240025.